Reply to 'Bayesian approaches in drug development: continuing the virtuous cycle'
Nat Rev Drug Discov
.
2024 Dec;23(12):964.
doi: 10.1038/s41573-024-01054-8.
Author
Stephen J Ruberg
1
Affiliation
1
Analytix Thinking, Indianapolis, IN, USA.
[email protected]
.
PMID:
39390293
DOI:
10.1038/s41573-024-01054-8
No abstract available
Publication types
Letter
Comment